SUPRIYA / NSE / Biotechnology & Drugs
Supriya Lifescience
1Y Price Trend
Key Information
Recommendations
RatingBuy
Target High1,085.5
Target Low545.65
Target Mean2
Target Median25
Risk Metrics
Overall RiskHigh risk
Board Risk52.38
Key Analysis
Overall score, performance score, return rating, defensive, aggressive, and balanced views.
Download appProjection Analytics
Best-case, base-case, worst-case, and dynamic AI projection views.
Download appLatest stock news
Sumeet Bagadia recommends five breakout stocks to buy today - Faze Three, SeQuent Scientific, Control Print, Anand Rathi Share and Stock Brokers, and Supriya Lifescience.
Shares of Wockhardt rallied over 10%, leading the recovery in the sector. Bajaj Healthcare, Supriya Lifescience, Alembic Pharmaceuticals, Aster DM Healthcare, Sun Pharmaceutical Industries, Lupin, Cipla, Aarti Drugs, Zydus Lifesciences, Biocon, and others gained between 1–3%.
Q4 results on May 27: LIC, Bosch, Info Edge, P&G Hygiene, Minda Corp, JK Lakshmi Cement, and Supriya Lifesciences are among 301 companies to release their earnings report today.
Sumeet Bagadia recommended buying these seven breakout shares to buy today - Nalwa Sons Investments, Supriya Lifescience, KPR Mill, Godawari Power and Ispat, and Shyam Metalics and Energy.
Discover the top stocks recommended by Raja Venkataraman and MarketSmith India for Tuesday, 25 March.
Best stock picks for today: Raja Venkatraman of NeoTrader recommends these stocks for Tuesday, 25 March
Stock Market Today: Supriya Lifescience share price rises 8% to 52-week high during the intraday trades. The stock that closed at ₹ 532.15 , up 4.36% has almost doubled in a year. Rising Developed market sales are driving growth, Check for details-
NSE Nifty and BSE Sensex end lower. MPS, GE Power India, and Star Cement hit 52-week highs.
© SharekeyX | Rusaka Technologies 2024-2026

